Bio Impact Capital LLC Stoke Therapeutics, Inc. Transaction History
Bio Impact Capital LLC
- $540 Million
- Q1 2025
A detailed history of Bio Impact Capital LLC transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Bio Impact Capital LLC holds 693,988 shares of STOK stock, worth $8.07 Million. This represents 0.85% of its overall portfolio holdings.
Number of Shares
693,988
Previous 685,826
1.19%
Holding current value
$8.07 Million
Previous $7.56 Million
38.99%
% of portfolio
0.85%
Previous 1.13%
Shares
3 transactions
Others Institutions Holding STOK
# of Institutions
134Shares Held
60.4MCall Options Held
5.6KPut Options Held
142K-
Skorpios Trust6.91MShares$80.3 Million99.7% of portfolio
-
Black Rock Inc. New York, NY5.41MShares$62.9 Million0.0% of portfolio
-
Lynx1 Capital Management LP San Juan, PR5.29MShares$61.5 Million13.01% of portfolio
-
Rtw Investments, LP New York, NY5.12MShares$59.6 Million0.56% of portfolio
-
Baker Bros. Advisors LP New York, NY4.63MShares$53.9 Million0.37% of portfolio
About Stoke Therapeutics, Inc.
- Ticker STOK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,419,300
- Market Cap $458M
- Description
- Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...